This is a revised application for a 5-year study of cellular and molecular mechanisms of pthalocyanine-sensitized photodynamic therapy (PcPDT) of skin tumors and of the associated cutaneous photosensitivity. Pthalocyanins (Pcs) sensitize tumor cells to damage by subsequent red light exposure. The hypothesis to be examined is that PcPDT activates membrane-localized enzymes, some of which are components of normal signal transduction pathways, leading to cell death. It is postulated that pathways that cause direct vs. indirect cell death in tumors, and for tumor cell death vs. cutaneous photosensitivity may vary. Manipulations of such pathways to enhance cell death and minimize photosensitivity will be explored. The four specific aims remain the same, but have been reordered as suggested by the last review. Now, the first two aims will address the relevance of apoptosis in PcPDT. 1) Whether murine papillomas or squamous cell carcinomas induced by chemical carcinogens or by UVB radiation undergo apoptosis during PcPDT ablation will be examined by first optimizing conditions for production of apoptosis, then by attempting to block apoptosis by basic fibroblast growth factor or enhance it by dexamethasone, with assessment of apoptosis by DNA fragmentation, histology, direct immunoperoxidase staining of digoxigenin-labeled genomic DNA in sections, or flow cytometry. 2) The cellular target of apoptosis will be studied in RIF-1 tumors in which apoptosis occurs during PcPDT tumor shrinkage in vivo, but not in vitro. This disparity will be exploited to elucidate differences in in vitro vs. in vivo mechanisms of PcPDT cell killing. RIF-1 tumor cell DNA will be tagged with transfected bacterial lac-Z genes to permit identifying malignant vs. infiltrating host cells when tagged RIF-1 cells are implanted into host mice and grow into tumors. The occurrence of apoptosis and the cell lines involved will be explored in histologic sections, with X-gal incubation or in situ hybridization with lac-Z insert as probe to identify tagged cells, by assessing DNA fragmentation, and by flow cytometry. If RIF-1 cells show apoptosis in vivo, it will be concluded that culture conditions lack factors necessary for direct PDT induction of apoptosis. Next, the mechanism for in vivo apoptosis of RIF-1 cells will be studied by comparing the extent and time course of apoptosis in tumors derived from cells expressing transfected human bcl-2 gene vs wild type cells. In vitro expression of bcl-2 gene appears to prevent apoptosis is several cell types. Similar incidence of apoptosis in transfected and wild cells will indicate that bcl-2 protein does not block direct PDT causation of apoptosis; dissimilar incidence will be taken as evidence that mechanisms of cell killing differ in vivo and in vitro, and that vascular effects must figure importantly in PcPDT damage in vivo. 3) Signal transduction in PcPDT-induced cell killing will be investigated to define its mechanisms. Signalling events will be studied in human epidermoid squamous cell carcinoma A431 cells vs. normal human epidermal keratinocytes. Pathways to be studied include protein tyrosine phosphorylation, breakdown of membrane phospholipids, release of intracellular Ca++, and activation of protein kinase C (PKC). Essential signalling events will be identified by using inhibitors of specific metabolic events. 4) The mechanism of PcPDT-related cutaneous photosensitivity will be studied by evaluating the roles of various toxic oxygen intermediaries or vasoactive amines. Pc-sensitized normal or tumor-bearing C3H/HeN mice will be given quenchers of superoxide anion, hydroxyl radical, hydrogen peroxide, or singlet oxygen, with or without quencher-inhibitors, prior to irradiation, then ear swelling and footpad damage will be quantified to assess which oxygen species is/are produced. Histamine H1 and H2 blockers will be similarly tested for suppressive effects. Agents found to be effective will then be tested for abrogation of photosensitivity by administration to mice after Pc-PDT of skin tumors, and reexposure to light radiation vs. controls.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA051802-09
Application #
2894825
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Moshell, Alan N
Project Start
1990-04-15
Project End
2001-05-31
Budget Start
1999-06-01
Budget End
2001-05-31
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Dermatology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Subbarayan, Murugesan; Hafeli, Urs O; Feyes, Denise K et al. (2003) A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med 44:650-6
Wang, Steven I; Mukhtar, Hasan (2002) A high-efficiency translational control element with potential for cancer gene therapy. Int J Oncol 20:1269-74
Ahmad, N; Kalka, K; Mukhtar, H (2001) In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy. Oncogene 20:2314-7
Azizuddin, K; Kalka, K; Chiu, S M et al. (2001) Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells. Int J Oncol 18:411-5
Srivastava, M; Ahmad, N; Gupta, S et al. (2001) Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis. J Biol Chem 276:15481-8
Elmets, C A; Singh, D; Tubesing, K et al. (2001) Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 44:425-32
Katiyar, S K; Mukhtar, H (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J Leukoc Biol 69:719-26
Kalka, K; Merk, H; Mukhtar, H (2000) Photodynamic therapy in dermatology. J Am Acad Dermatol 42:389-413; quiz 414-6
Ahmad, N; Gupta, S; Feyes, D K et al. (2000) Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells. J Invest Dermatol 115:1041-6
Whitacre, C M; Feyes, D K; Satoh, T et al. (2000) Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. Clin Cancer Res 6:2021-7

Showing the most recent 10 out of 42 publications